JP2008517045A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008517045A5 JP2008517045A5 JP2007537367A JP2007537367A JP2008517045A5 JP 2008517045 A5 JP2008517045 A5 JP 2008517045A5 JP 2007537367 A JP2007537367 A JP 2007537367A JP 2007537367 A JP2007537367 A JP 2007537367A JP 2008517045 A5 JP2008517045 A5 JP 2008517045A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cancer
- derivative
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 206010028980 Neoplasm Diseases 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 239000013543 active substance Substances 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 102000027313 Epiphycan Human genes 0.000 claims 2
- 108091013881 Epiphycan Proteins 0.000 claims 2
- 102000027307 Mimecan Human genes 0.000 claims 2
- 108091013859 Mimecan Proteins 0.000 claims 2
- 102100025913 Opticin Human genes 0.000 claims 2
- 101710152613 Opticin Proteins 0.000 claims 2
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 150000008574 D-amino acids Chemical class 0.000 claims 1
- 201000008808 Fibrosarcoma Diseases 0.000 claims 1
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 108010043958 Peptoids Proteins 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 230000006907 apoptotic process Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 210000004901 leucine-rich repeat Anatomy 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000004898 n-terminal fragment Anatomy 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0423273.2A GB0423273D0 (en) | 2004-10-20 | 2004-10-20 | Treatment of cancer |
| PCT/GB2005/003940 WO2006043031A2 (en) | 2004-10-20 | 2005-10-13 | Class iii slrp for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008517045A JP2008517045A (ja) | 2008-05-22 |
| JP2008517045A5 true JP2008517045A5 (enExample) | 2008-12-04 |
Family
ID=33484868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007537367A Abandoned JP2008517045A (ja) | 2004-10-20 | 2005-10-13 | 癌の治療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080096793A1 (enExample) |
| EP (1) | EP1809314A2 (enExample) |
| JP (1) | JP2008517045A (enExample) |
| CA (1) | CA2626774A1 (enExample) |
| GB (1) | GB0423273D0 (enExample) |
| WO (1) | WO2006043031A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004105784A1 (en) * | 2003-05-29 | 2004-12-09 | The University Of Manchester | Class iii slrp agonists for the reduction of blood vessel formation |
| CN102549436A (zh) | 2009-07-27 | 2012-07-04 | 霍夫曼-拉罗奇有限公司 | mimecan在评价心力衰竭中的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5827702A (en) * | 1994-10-31 | 1998-10-27 | Genentech, Inc. | Ocular gene therapy |
| DE4445630A1 (de) * | 1994-12-21 | 1996-06-27 | Forssmann Wolf Georg | Humane zirkulierende Peptidfragmente 20-92 und 23-74 des Precursor des Osteoinduktiven Faktors kurz: OIF-20-92 und OIF 23-74 |
| AU5593398A (en) * | 1996-12-05 | 1998-06-29 | Alcon Laboratories, Inc. | The use of inhibitors of tgf-beta's functions to ameliorate ocular pathology |
| WO2000068264A2 (en) * | 1999-05-10 | 2000-11-16 | The Texas A & M University System | A peptide inhibitor of fibrinogen blood clotting |
| US7304137B2 (en) * | 2001-12-13 | 2007-12-04 | The Texas A & M University System | Nucleotide and amino acid sequences of asporins |
| WO2004105784A1 (en) * | 2003-05-29 | 2004-12-09 | The University Of Manchester | Class iii slrp agonists for the reduction of blood vessel formation |
-
2004
- 2004-10-20 GB GBGB0423273.2A patent/GB0423273D0/en not_active Ceased
-
2005
- 2005-10-13 JP JP2007537367A patent/JP2008517045A/ja not_active Abandoned
- 2005-10-13 US US11/577,658 patent/US20080096793A1/en not_active Abandoned
- 2005-10-13 WO PCT/GB2005/003940 patent/WO2006043031A2/en not_active Ceased
- 2005-10-13 EP EP05799897A patent/EP1809314A2/en not_active Withdrawn
- 2005-10-13 CA CA002626774A patent/CA2626774A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013001749A (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
| JP2007526248A5 (enExample) | ||
| JP2009500431A5 (enExample) | ||
| EA200900667A1 (ru) | Селективные аналоги глюкагонподобного пептида-2 (glp-2) | |
| WO2005072061A3 (en) | Conjugates for cancer therapy and diagnosis | |
| JP2011521897A5 (enExample) | ||
| JP2014513952A5 (enExample) | ||
| ATE543507T1 (de) | Sdf-1 enthaltende zusammensetzung mit anhaltender freisetzung | |
| JP2011516501A5 (enExample) | ||
| JP2010524968A5 (enExample) | ||
| JP2007530584A5 (enExample) | ||
| EP2175879A4 (en) | TREATMENT OF DISEASES ASSOCIATED WITH PRION PROTEIN | |
| JP2010536714A5 (enExample) | ||
| WO2008031016A3 (en) | Heterocyclic ligands for integrin imaging and therapy | |
| WO2020103961A9 (zh) | 一种脑部肿瘤靶向肽及其应用 | |
| WO2002100885A3 (en) | A penta- or tetrapeptide binding to somatostatin receptors and the use of the same | |
| AR069767A1 (es) | Tratamiento del melanoma con peptidos timosina alfa en combinacion con activador de apoptosis de choque termico entineoplastico (hsaa) | |
| JP2008517045A5 (enExample) | ||
| MX2008011473A (es) | El uso de la nicotina, sus analogos, sus precursores o sus derivados en el tratamiento de diversos procesos patologicos susceptible de mejorar con (-msh administrada en forma profilactica o terapeutica. | |
| JP2010537623A5 (enExample) | ||
| JP2009516719A5 (enExample) | ||
| EP4282490A3 (en) | Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy | |
| JP2007502855A5 (enExample) | ||
| JP2008502323A5 (enExample) | ||
| EA200801670A1 (ru) | Комбинированная противораковая терапия с перфузией изолированного органа |